Top Regulatory Tips: Tips 3 & 4

Tuesday, March 10, 2009

Part 2 of Top Regulatory Tips

View part: [ 1 | 2 | 3 | 4 | 5 ]

Previously:
« Tips 1 & 2

Next:
Tips 5 & 6 »


Tip 3: Quality systems should go in sooner rather than later

Qualtiy systems that grow with a company are always better developed and cost effective than those that are layered on during later stages. Personnel need to understand, on a deep level, the systems that go into designing and manufacturing processes. This is far easier to attain when quality systems are an ingrained, integral part of how your business operates.

Tip 4: Listen to the FDA

FDA is one of your most important customers but it can pretty difficult to hear what they have to say ... espeically when they have reservations about your product's intended use or design. Try to listen with an open mind and even if ultimately the suggested changes are not incorproated into your product, be sure that FDA understands how the design you've chosen addresses their concerns. Also, if FDA has decided that your product will be a Class III or PMA, it's not the end of the world. FDA, particularly OIVD, will work with you to clear this hurdle. Try to hear their decision as a challenge instead of an impenetrable road block.

Tags: Best Practices, Design Control, FDA, FDA 101, QSR

Part 2 of Top Regulatory Tips

View part: [ 1 | 2 | 3 | 4 | 5 ]

Previously:
« Tips 1 & 2

Next:
Tips 5 & 6 »


Other Blog Authors

Dylan Reinhardt
Dave Kern
Steve Gutman
Jo-Ann Gonzales

Recent Blog Posts

The Staple That Changed an Industry LDT regulation and the perils of challenging Eminem to a rap battle
FDA Releases the Kraken Whichever way this breaks, it's long past time to have this conversation in a meaningful way
Illumina Acquires Myraqa Acquisition Strengthens Illumina’s Clinical Readiness
The Spirit of GLP A Best Practice for IVDs
Process Performance Qualification (PPQ) Lots So, how many lots are required?
The Case for Risk-based Monitoring Better the devil you know...
Form Follows Function OIR Reorganizes to Meet the Advancing Wave of Molecular Diagnostics
CDRH Unveils New PMA Guidance Documents Attention shoppers, it's two-for-one day!